---
title: "FOLFIRI"
slug: "folfiri"
date: "2023-09-14"
enableToc: false
tags:
  - building
---

> [!info]
>
> ðŸŒ± ä¾†è‡ª: [[Irinotecan]]

# FOLFIRI

- [[Irinotecan]] `180` mg/m2 IV Dilute in 500 mL D5W and administer over 90 minutes (can be administered concurrently with leucovorin via y-site connection). Day 1
- Leucovorin 400 mg/m2 IV Dilute in 250 mL D5W and administer over two hours. Day 1
- [[Fluorouracil]] (FU), bolus 400 mg/m2 IV Slow IV push over five minutes (administer immediately after leucovorin). Day 1
- FU, infusional 2400 mg/m2 IV Dilute in 500 to 1000 mL D5WÂ¶ and administer over 46 hours. To accommodate an ambulatory pump for outpatient treatment, can be administered undiluted (50 mg/mL) or the total dose can be diluted in 100 to 150 mL NS.Â¶ Day 1

---

## Fluorouracil

- [[5-FU]]
- (5-FU, Adrucil)
- Dosing:
  - Dose, schedule, & administration (IVB vs. IV continuous infusion) are based on malignancy.
  - Common ranges,
    - IVB: 400-600 mg/m2/dose;
    - IV continuous infusion 200-1,500 mg/m2/d.
  - No renal or hepatic dose adjustments recommended;
    - use w/ caution
- PK/PD:
  - Extensive tissue distribution;
  - saturable catabolism;
  - excretion via metabolism, lung, & urine;
  - T1/2 `8-20 min` after IVB
- [[AEs of Fluorouracil|AEs]] ó°’–: ðŸ’©ðŸ‘„ðŸ¤®ðŸ©¸ðŸ¤žðŸ«€ðŸ‘ï¸ðŸ–ï¸ðŸ¦¶ðŸ˜‡ðŸŒ
- DDI: CYP2C9 substrates (â†“ substrate levels),
  - cimetidine (â†“ clearance of 5-FU),
  - oral anticoagulants (â†‘ levels of anticoagulants),
  - leucovorin (â†‘ tox of 5-FU)
- Clinical pearls:
  - AEs w/ DPD deficiency (prolonged clearance, â†‘ tox), radiosensitizer;
  - leucovorin is â†’ given w/ bolus administration to â†‘ intracellular half-life of 5-FU (â†‘ cytotoxicity).
  - [[Uridine triacetate]] used as antidote in cases of overdose or DPD deficiency

> [[Fluorouracil]]
